SCHEMBL6789604

SCHEMBL6789604

Cc1ccc(C#N)[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3293710 0.80
SCHEMBL6443242 0.74
SCHEMBL13074417 0.72 AR (0.52)
SCHEMBL65952 0.69
SCHEMBL5154501 0.68
SCHEMBL11392877 0.68
SCHEMBL1201107 0.67 KDM4E (0.53)
SCHEMBL8619374 0.66
SCHEMBL28896011 0.66 HMBS (0.92)
SCHEMBL27763219 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111511750-B Macrocyclic derivatives, process for their preparation and pharmaceutical compositions containing them 法国施维雅药厂 2023-06-13 CN claimed
CN-112585132-B Proteasome activity enhancing compounds 优曼尼蒂公司 2025-02-28 CN disclosed
US-20240317705-A1 POTASSIUM CHANNEL MODULATORS NOVARTIS AG (CH) 2024-09-26 US disclosed
US-20240285611-A1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBVIE INC. (US) 2024-08-29 US disclosed
US-20240245699-A1 PYRROLE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SERVIER LAB (FR) 2024-07-25 US disclosed
CN-118307623-A Steroid compound, application thereof and pharmaceutical composition containing steroid compound 北京华睿鼎信科技有限公司 2024-07-09 CN disclosed
US-11833162-B2 Macrocyclic derivatives, process for preparing same and pharmaceutical compositions containing same LES LABORATOIRES SERVIER (FR) 2023-12-05 US disclosed
US-11786519-B2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases ABBVIE INC. (US) 2023-10-17 US disclosed
EP-3700911-B1 NOVEL MACROCYCLIC DERIVATIVES, PROCESS FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME SERVIER LAB (FR) 2023-09-06 EP disclosed
US-20230265077-A1 Photoactive Compound, Photoactive Protein-Immobilizing Gel And Use Water Bear Health Technology (Nantong) Co., LTD. (CN) 2023-08-24 US disclosed
WO-2011050160-A1 PHARMACEUTICALS, COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME BIOGEN IDEC MA INC. (US) 2011-04-28 WO disclosed
EP-1756095-B1 CYANOPYRROLE CONTAINING CYCLIC CARBAMATE AND THIOCARBAMATE BIARYLS AND METHODS FOR PREPARING THE SAME WYETH CORP (US) 2008-05-21 EP disclosed
US-20040077880-A1 Sulfonylpyrroles BAYER CROPSCIENCE AG (DE) 2004-04-22 US disclosed
EP-1345934-A2 SULFONYLPYRROLES Bayer CropScience AG (DE) 2003-09-24 EP disclosed
WO-2002050069-A2 SULFONYLPYRROLES FOR CONTROLLING MICROORGANISMS BAYER CROPSCIENCE AG (DE) 2002-06-27 WO disclosed
CN-1077955-A Hete rocyclic derivatives FUJISAWA PHARMACEUTICAL CO (JP) 1993-11-03 CN disclosed
EP-0079623-B1 PROCESS FOR THE PREPARATION OF 1H-PYRROLE-2-ACETIC ESTERS RÜTGERSWERKE AKTIENGESELLSCHAFT (DE) 1985-08-21 EP disclosed
US-4493935-A SAPONIFICATION IH-PYRROL-2-ACETONITRILE (OR-ACETAMIDE), THEN 7AR-) RUTGERSWERKE AKTIENGESELLSCHAFT (DE) 1985-01-15 US disclosed
EP-0079623-A2 Process for the preparation of 1H-pyrrole-2-acetic esters RÜTGERSWERKE AKTIENGESELLSCHAFT (DE) 1983-05-25 EP disclosed
US-4006160-A Process for the synthesis of N-hydroxypyrroles, N-hydroxyimidazoles, and derivatives thereof UNIVERSITY OF ALABAMA (US) 1977-02-01 US disclosed